# The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)

> **NCT00957190** · PHASE4 · COMPLETED · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 25 (actual)

## Conditions studied

- Eye Disease

## Interventions

- **DRUG:** Dorzolamide 20 mg and Timolol 5 mg

## Key facts

- **NCT ID:** NCT00957190
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-04
- **Primary completion:** 2011-09-14
- **Final completion:** 2012-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957190, "The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00957190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*